Review



rabbit monoclonal anti psmad2  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc rabbit monoclonal anti psmad2
    Rabbit Monoclonal Anti Psmad2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit monoclonal anti psmad2/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    rabbit monoclonal anti psmad2 - by Bioz Stars, 2026-06
    86/100 stars

    Images



    Similar Products

    94
    Bioss psmad2
    Ti and ZrO 2 implants induce early osseointegration and immune inflammation. (A) Transcriptional levels of osteogenesis-related and immune-inflammatory genes. Osteogenic genes: Runx2 , Osterix , and Tgfb1 . Immune-inflammatory genes: Il1b , Mmp9 , and Il23a . (B) Receiver operating characteristic (ROC) analysis based on bulk RNA-seq data. AUC, area under the curve. (C) Protein expression levels of osteogenesis-related and immune-inflammatory markers. Osteogenic proteins: RUNX2, OSX, TGFB1, <t>pSMAD2/SMAD2,</t> and pSMAD3/SMAD3. Immune-inflammatory proteins: IL1B, MMP9, and IL23A. (D) Statistical analysis of protein expression levels. Statistical significance was determined using one-way analysis of variance. RUNX2, RUNX family transcription factor 2; OSX, osterix; TGFB1, transforming growth factor beta 1; SMAD2, SMAD family member 2; SMAD3, SMAD family member 3; IL1B, interleukin 1 beta; MMP9, matrix metallopeptidase 9; IL23A, interleukin 23 subunit alpha.
    Psmad2, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/psmad2/product/Bioss
    Average 94 stars, based on 1 article reviews
    psmad2 - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc rabbit monoclonal anti psmad2
    Ti and ZrO 2 implants induce early osseointegration and immune inflammation. (A) Transcriptional levels of osteogenesis-related and immune-inflammatory genes. Osteogenic genes: Runx2 , Osterix , and Tgfb1 . Immune-inflammatory genes: Il1b , Mmp9 , and Il23a . (B) Receiver operating characteristic (ROC) analysis based on bulk RNA-seq data. AUC, area under the curve. (C) Protein expression levels of osteogenesis-related and immune-inflammatory markers. Osteogenic proteins: RUNX2, OSX, TGFB1, <t>pSMAD2/SMAD2,</t> and pSMAD3/SMAD3. Immune-inflammatory proteins: IL1B, MMP9, and IL23A. (D) Statistical analysis of protein expression levels. Statistical significance was determined using one-way analysis of variance. RUNX2, RUNX family transcription factor 2; OSX, osterix; TGFB1, transforming growth factor beta 1; SMAD2, SMAD family member 2; SMAD3, SMAD family member 3; IL1B, interleukin 1 beta; MMP9, matrix metallopeptidase 9; IL23A, interleukin 23 subunit alpha.
    Rabbit Monoclonal Anti Psmad2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit monoclonal anti psmad2/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    rabbit monoclonal anti psmad2 - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc psmad2
    A. Schematic showing two possible mechanisms to spatially pattern proliferation in the embryonic lung. B. Representative immunoblots for <t>pSMAD2</t> and GAPDH in lungs cultured with RepSox or vehicle control, and graph showing the normalized pSMAD2 band intensity from 3 replicates. Shown are the average and s.d. of normalized intensity of the pSMAD2 band. C. Fluorescence images of EdU incorporation in the epithelium and mesenchyme of lung explants cultured with RepSox or vehicle control. White arrows denote closely apposed branch stalks. Solid and dotted boxes denote the regions between b1 and b2, respectively. Scale bars, 100 µm. D. Graph showing the percentage of EdU-positive epithelial cells in lung explants cultured with RepSox or vehicle control. Shown are the average and s.d. of 6 lungs per condition. n.s. stands for not significant. *** p <0.001. E. Graph showing the percentage of EdU-positive mesenchymal cells in lung explants cultured with RepSox or vehicle control. Shown are the average and s.d. of 3 lungs per condition. ** p <0.005. F. Graph showing the density of mesenchymal cells near the tip in lung explants cultured with RepSox or vehicle control. Shown are the average and s.d. of at least 4 lungs per condition. * p <0.05.
    Psmad2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/psmad2/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    psmad2 - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc mouse psmad2
    Conditional knockout of Tgfβ1 in macrophage lineage cells reduces <t>pSmad2</t> levels and promotes functional recovery in SCI mice. a – d ELISA analysis showing the concentration of TGF-β in the spinal cord and the serum after SCI in each mouse for the groups indicated (* P < 0.05, ** P < 0.01, n = 4). e Representative Western blots showing the activation of phosphorylated Smad (pSmad) signaling. f Representative images of immunofluorescent staining of pSmad2 + (red), platelet-derived growth factor receptor-β + (PDGFR-β + ) (green) pericytes , and DAPI (blue) staining of nuclei at 7 days after SCI. Scale bar, 10 µm. g Representative immunofluorescence images of PDGFR-β + (green) pericytes and DAPI (blue) staining of nuclei at 2 weeks after SCI. Scale bars, 200 µm. h Quantitative analysis of the number of pSmad2 + cells (**** P < 0.000 1, n = 6). i Quantitative analysis of the number of PDGFR-β + cells (** P < 0.01, n = 6). j , k Illustrations of the hot plate test and the von Frey test. l Quantitative analysis of hindpaw withdrawal time responding to temperature (hot plate test, ** P < 0.01, n = 8). m , n Quantitative analysis of hindpaw withdrawal frequency responding to mechanical stimulation (von Frey test, 0.7 mN and 3.9 mN, * P < 0.05, ** P < 0.01, n = 8). o Quantitative analysis of Basso Mouse Scale (BMS) score between Tgfb1 flox / flox control mice after SCI, Tgfb1 LysM-cre −/− mice after SCI, and Tgfb1 flox/flox control mice without SCI (* P < 0.05, n = 8). PWF paw withdrawal frequency. LF left forepaw, RF right forepaw, RH right hindpaw. Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file
    Mouse Psmad2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse psmad2/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    mouse psmad2 - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc antibody anti psmad2
    Conditional knockout of Tgfβ1 in macrophage lineage cells reduces <t>pSmad2</t> levels and promotes functional recovery in SCI mice. a – d ELISA analysis showing the concentration of TGF-β in the spinal cord and the serum after SCI in each mouse for the groups indicated (* P < 0.05, ** P < 0.01, n = 4). e Representative Western blots showing the activation of phosphorylated Smad (pSmad) signaling. f Representative images of immunofluorescent staining of pSmad2 + (red), platelet-derived growth factor receptor-β + (PDGFR-β + ) (green) pericytes , and DAPI (blue) staining of nuclei at 7 days after SCI. Scale bar, 10 µm. g Representative immunofluorescence images of PDGFR-β + (green) pericytes and DAPI (blue) staining of nuclei at 2 weeks after SCI. Scale bars, 200 µm. h Quantitative analysis of the number of pSmad2 + cells (**** P < 0.000 1, n = 6). i Quantitative analysis of the number of PDGFR-β + cells (** P < 0.01, n = 6). j , k Illustrations of the hot plate test and the von Frey test. l Quantitative analysis of hindpaw withdrawal time responding to temperature (hot plate test, ** P < 0.01, n = 8). m , n Quantitative analysis of hindpaw withdrawal frequency responding to mechanical stimulation (von Frey test, 0.7 mN and 3.9 mN, * P < 0.05, ** P < 0.01, n = 8). o Quantitative analysis of Basso Mouse Scale (BMS) score between Tgfb1 flox / flox control mice after SCI, Tgfb1 LysM-cre −/− mice after SCI, and Tgfb1 flox/flox control mice without SCI (* P < 0.05, n = 8). PWF paw withdrawal frequency. LF left forepaw, RF right forepaw, RH right hindpaw. Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file
    Antibody Anti Psmad2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody anti psmad2/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    antibody anti psmad2 - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc antibodies to psmad2
    Conditional knockout of Tgfβ1 in macrophage lineage cells reduces <t>pSmad2</t> levels and promotes functional recovery in SCI mice. a – d ELISA analysis showing the concentration of TGF-β in the spinal cord and the serum after SCI in each mouse for the groups indicated (* P < 0.05, ** P < 0.01, n = 4). e Representative Western blots showing the activation of phosphorylated Smad (pSmad) signaling. f Representative images of immunofluorescent staining of pSmad2 + (red), platelet-derived growth factor receptor-β + (PDGFR-β + ) (green) pericytes , and DAPI (blue) staining of nuclei at 7 days after SCI. Scale bar, 10 µm. g Representative immunofluorescence images of PDGFR-β + (green) pericytes and DAPI (blue) staining of nuclei at 2 weeks after SCI. Scale bars, 200 µm. h Quantitative analysis of the number of pSmad2 + cells (**** P < 0.000 1, n = 6). i Quantitative analysis of the number of PDGFR-β + cells (** P < 0.01, n = 6). j , k Illustrations of the hot plate test and the von Frey test. l Quantitative analysis of hindpaw withdrawal time responding to temperature (hot plate test, ** P < 0.01, n = 8). m , n Quantitative analysis of hindpaw withdrawal frequency responding to mechanical stimulation (von Frey test, 0.7 mN and 3.9 mN, * P < 0.05, ** P < 0.01, n = 8). o Quantitative analysis of Basso Mouse Scale (BMS) score between Tgfb1 flox / flox control mice after SCI, Tgfb1 LysM-cre −/− mice after SCI, and Tgfb1 flox/flox control mice without SCI (* P < 0.05, n = 8). PWF paw withdrawal frequency. LF left forepaw, RF right forepaw, RH right hindpaw. Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file
    Antibodies To Psmad2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies to psmad2/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    antibodies to psmad2 - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    Image Search Results


    Ti and ZrO 2 implants induce early osseointegration and immune inflammation. (A) Transcriptional levels of osteogenesis-related and immune-inflammatory genes. Osteogenic genes: Runx2 , Osterix , and Tgfb1 . Immune-inflammatory genes: Il1b , Mmp9 , and Il23a . (B) Receiver operating characteristic (ROC) analysis based on bulk RNA-seq data. AUC, area under the curve. (C) Protein expression levels of osteogenesis-related and immune-inflammatory markers. Osteogenic proteins: RUNX2, OSX, TGFB1, pSMAD2/SMAD2, and pSMAD3/SMAD3. Immune-inflammatory proteins: IL1B, MMP9, and IL23A. (D) Statistical analysis of protein expression levels. Statistical significance was determined using one-way analysis of variance. RUNX2, RUNX family transcription factor 2; OSX, osterix; TGFB1, transforming growth factor beta 1; SMAD2, SMAD family member 2; SMAD3, SMAD family member 3; IL1B, interleukin 1 beta; MMP9, matrix metallopeptidase 9; IL23A, interleukin 23 subunit alpha.

    Journal: Research

    Article Title: Mapping Immune-Inflammatory Niches on Zirconia Bone Implants: Single-Cell Transcriptomic Profiling

    doi: 10.34133/research.1162

    Figure Lengend Snippet: Ti and ZrO 2 implants induce early osseointegration and immune inflammation. (A) Transcriptional levels of osteogenesis-related and immune-inflammatory genes. Osteogenic genes: Runx2 , Osterix , and Tgfb1 . Immune-inflammatory genes: Il1b , Mmp9 , and Il23a . (B) Receiver operating characteristic (ROC) analysis based on bulk RNA-seq data. AUC, area under the curve. (C) Protein expression levels of osteogenesis-related and immune-inflammatory markers. Osteogenic proteins: RUNX2, OSX, TGFB1, pSMAD2/SMAD2, and pSMAD3/SMAD3. Immune-inflammatory proteins: IL1B, MMP9, and IL23A. (D) Statistical analysis of protein expression levels. Statistical significance was determined using one-way analysis of variance. RUNX2, RUNX family transcription factor 2; OSX, osterix; TGFB1, transforming growth factor beta 1; SMAD2, SMAD family member 2; SMAD3, SMAD family member 3; IL1B, interleukin 1 beta; MMP9, matrix metallopeptidase 9; IL23A, interleukin 23 subunit alpha.

    Article Snippet: The membranes were blocked with 5% nonfat milk for 1 h, followed by overnight incubation at 4 °C with the following primary antibodies: RUNX2 (Bioss, bs-1134R, 1:1,000, China), OSX (Bioss, bs-25532R, 1:1,000, China), pSMAD2 (Bioss, bs-3419R, 1:1,000, China), pSMAD3 (Bioss, bs-3425R, 1:1,000, China), IL1B (Bioss, bs-0812R, 1:1,000, China), MMP9 (Bioss, bsm-54040R, 1:3,000, China), IL23A (Bioss, bs-1193R, 1:1,000, China), NOS2 (Bioss, bs-0162R, 1:2,000, China), CD206 (Bioss, bsm-55604R, 1:1,000, China), TGFB1 (Proteintech, 81746-2-RR, 1:1,000, China), SMAD2 (Proteintech, 12570-1-AP, 1:3,000, China), and SMAD3 (Proteintech, 30130-1-AP, 1:2,000, China).

    Techniques: RNA Sequencing, Expressing

    A. Schematic showing two possible mechanisms to spatially pattern proliferation in the embryonic lung. B. Representative immunoblots for pSMAD2 and GAPDH in lungs cultured with RepSox or vehicle control, and graph showing the normalized pSMAD2 band intensity from 3 replicates. Shown are the average and s.d. of normalized intensity of the pSMAD2 band. C. Fluorescence images of EdU incorporation in the epithelium and mesenchyme of lung explants cultured with RepSox or vehicle control. White arrows denote closely apposed branch stalks. Solid and dotted boxes denote the regions between b1 and b2, respectively. Scale bars, 100 µm. D. Graph showing the percentage of EdU-positive epithelial cells in lung explants cultured with RepSox or vehicle control. Shown are the average and s.d. of 6 lungs per condition. n.s. stands for not significant. *** p <0.001. E. Graph showing the percentage of EdU-positive mesenchymal cells in lung explants cultured with RepSox or vehicle control. Shown are the average and s.d. of 3 lungs per condition. ** p <0.005. F. Graph showing the density of mesenchymal cells near the tip in lung explants cultured with RepSox or vehicle control. Shown are the average and s.d. of at least 4 lungs per condition. * p <0.05.

    Journal: bioRxiv

    Article Title: TGFβ determines epithelial tissue spacing by regulating mesenchymal condensation

    doi: 10.64898/2026.03.16.712215

    Figure Lengend Snippet: A. Schematic showing two possible mechanisms to spatially pattern proliferation in the embryonic lung. B. Representative immunoblots for pSMAD2 and GAPDH in lungs cultured with RepSox or vehicle control, and graph showing the normalized pSMAD2 band intensity from 3 replicates. Shown are the average and s.d. of normalized intensity of the pSMAD2 band. C. Fluorescence images of EdU incorporation in the epithelium and mesenchyme of lung explants cultured with RepSox or vehicle control. White arrows denote closely apposed branch stalks. Solid and dotted boxes denote the regions between b1 and b2, respectively. Scale bars, 100 µm. D. Graph showing the percentage of EdU-positive epithelial cells in lung explants cultured with RepSox or vehicle control. Shown are the average and s.d. of 6 lungs per condition. n.s. stands for not significant. *** p <0.001. E. Graph showing the percentage of EdU-positive mesenchymal cells in lung explants cultured with RepSox or vehicle control. Shown are the average and s.d. of 3 lungs per condition. ** p <0.005. F. Graph showing the density of mesenchymal cells near the tip in lung explants cultured with RepSox or vehicle control. Shown are the average and s.d. of at least 4 lungs per condition. * p <0.05.

    Article Snippet: Samples were then incubated with primary antibodies against E-cadherin (1:100; BD Biosciences, 610182), pSMAD1/5/9 (1:100; Invitrogen, PA5-64711), pan-laminin (1:100; Invitrogen, PA1-16730), perlecan (1:100; Invitrogen, MA1-06821), or pSMAD2 (1:100; Cell Signaling, 18338).

    Techniques: Western Blot, Cell Culture, Control, Fluorescence

    ( A ) Fluorescence images of nuclei (blue) and EdU incorporation (red) in lung explants inserted with TGFβ-containing bead or vehicle control. The beads were inserted proximal to b1. In contrast to control, few EdU-positive mesenchymal cells are observed in TGFβ-containing bead-inserted lung. White arrows denote proximal stalk of b1. ( B ) Fluorescence images of epithelium in branch-implanted lung explants treated with RepSox or vehicle control. The distance between implanted and native branches is small in RepSox-treated lungs. Scale bars, 100 µm and 10 µm (inset). ( C ) Fluorescence images of nuclei in lung explants cultured for 12- or 24-hours after implantation of beads with different TGFβ concentrations. ( D ) Graph showing the sizes of condensations in bead-implanted lung explants with different initial TGFβ concentration and culture time. ( E ) Fluorescence images of nuclei (blue) and pSMAD2 (red) counterstained for E-cadherin (green). Strong circular pSMAD2 staining is observed near TGFβ-containing beads. ( F ) Fluorescence images of nuclei (blue) and perlecan (red) in lung explants inserted with TGFβ-containing bead or vehicle control. Strong perlecan staining is observed in mesenchymal condensations near TGFβ-containing beads. ( G ) Fluorescence images of nuclei in lung explants cultured with or without RepSox after being inserted with TGFβ-containing beads or vehicle control. Mesenchymal condensations are only observed in lungs inserted with TGFβ-containing beads and cultured without RepSox. ( H ) pSMAD2 staining and nuclear-masked pSMAD2 staining intensity near the branch. Scale bar, 50 µm. Subepithelial mesenchymal cells exhibit strong pSMAD2 staining. Cyan dotted lines denote condensations ( D, F, G ). Scale bars, 100 µm ( A, C, E, F, G ).

    Journal: bioRxiv

    Article Title: TGFβ determines epithelial tissue spacing by regulating mesenchymal condensation

    doi: 10.64898/2026.03.16.712215

    Figure Lengend Snippet: ( A ) Fluorescence images of nuclei (blue) and EdU incorporation (red) in lung explants inserted with TGFβ-containing bead or vehicle control. The beads were inserted proximal to b1. In contrast to control, few EdU-positive mesenchymal cells are observed in TGFβ-containing bead-inserted lung. White arrows denote proximal stalk of b1. ( B ) Fluorescence images of epithelium in branch-implanted lung explants treated with RepSox or vehicle control. The distance between implanted and native branches is small in RepSox-treated lungs. Scale bars, 100 µm and 10 µm (inset). ( C ) Fluorescence images of nuclei in lung explants cultured for 12- or 24-hours after implantation of beads with different TGFβ concentrations. ( D ) Graph showing the sizes of condensations in bead-implanted lung explants with different initial TGFβ concentration and culture time. ( E ) Fluorescence images of nuclei (blue) and pSMAD2 (red) counterstained for E-cadherin (green). Strong circular pSMAD2 staining is observed near TGFβ-containing beads. ( F ) Fluorescence images of nuclei (blue) and perlecan (red) in lung explants inserted with TGFβ-containing bead or vehicle control. Strong perlecan staining is observed in mesenchymal condensations near TGFβ-containing beads. ( G ) Fluorescence images of nuclei in lung explants cultured with or without RepSox after being inserted with TGFβ-containing beads or vehicle control. Mesenchymal condensations are only observed in lungs inserted with TGFβ-containing beads and cultured without RepSox. ( H ) pSMAD2 staining and nuclear-masked pSMAD2 staining intensity near the branch. Scale bar, 50 µm. Subepithelial mesenchymal cells exhibit strong pSMAD2 staining. Cyan dotted lines denote condensations ( D, F, G ). Scale bars, 100 µm ( A, C, E, F, G ).

    Article Snippet: Samples were then incubated with primary antibodies against E-cadherin (1:100; BD Biosciences, 610182), pSMAD1/5/9 (1:100; Invitrogen, PA5-64711), pan-laminin (1:100; Invitrogen, PA1-16730), perlecan (1:100; Invitrogen, MA1-06821), or pSMAD2 (1:100; Cell Signaling, 18338).

    Techniques: Fluorescence, Control, Cell Culture, Concentration Assay, Staining

    Conditional knockout of Tgfβ1 in macrophage lineage cells reduces pSmad2 levels and promotes functional recovery in SCI mice. a – d ELISA analysis showing the concentration of TGF-β in the spinal cord and the serum after SCI in each mouse for the groups indicated (* P < 0.05, ** P < 0.01, n = 4). e Representative Western blots showing the activation of phosphorylated Smad (pSmad) signaling. f Representative images of immunofluorescent staining of pSmad2 + (red), platelet-derived growth factor receptor-β + (PDGFR-β + ) (green) pericytes , and DAPI (blue) staining of nuclei at 7 days after SCI. Scale bar, 10 µm. g Representative immunofluorescence images of PDGFR-β + (green) pericytes and DAPI (blue) staining of nuclei at 2 weeks after SCI. Scale bars, 200 µm. h Quantitative analysis of the number of pSmad2 + cells (**** P < 0.000 1, n = 6). i Quantitative analysis of the number of PDGFR-β + cells (** P < 0.01, n = 6). j , k Illustrations of the hot plate test and the von Frey test. l Quantitative analysis of hindpaw withdrawal time responding to temperature (hot plate test, ** P < 0.01, n = 8). m , n Quantitative analysis of hindpaw withdrawal frequency responding to mechanical stimulation (von Frey test, 0.7 mN and 3.9 mN, * P < 0.05, ** P < 0.01, n = 8). o Quantitative analysis of Basso Mouse Scale (BMS) score between Tgfb1 flox / flox control mice after SCI, Tgfb1 LysM-cre −/− mice after SCI, and Tgfb1 flox/flox control mice without SCI (* P < 0.05, n = 8). PWF paw withdrawal frequency. LF left forepaw, RF right forepaw, RH right hindpaw. Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file

    Journal: Bone Research

    Article Title: TGF-β-induced fibrotic scar formation limits recovery of spinal cord injury

    doi: 10.1038/s41413-026-00507-7

    Figure Lengend Snippet: Conditional knockout of Tgfβ1 in macrophage lineage cells reduces pSmad2 levels and promotes functional recovery in SCI mice. a – d ELISA analysis showing the concentration of TGF-β in the spinal cord and the serum after SCI in each mouse for the groups indicated (* P < 0.05, ** P < 0.01, n = 4). e Representative Western blots showing the activation of phosphorylated Smad (pSmad) signaling. f Representative images of immunofluorescent staining of pSmad2 + (red), platelet-derived growth factor receptor-β + (PDGFR-β + ) (green) pericytes , and DAPI (blue) staining of nuclei at 7 days after SCI. Scale bar, 10 µm. g Representative immunofluorescence images of PDGFR-β + (green) pericytes and DAPI (blue) staining of nuclei at 2 weeks after SCI. Scale bars, 200 µm. h Quantitative analysis of the number of pSmad2 + cells (**** P < 0.000 1, n = 6). i Quantitative analysis of the number of PDGFR-β + cells (** P < 0.01, n = 6). j , k Illustrations of the hot plate test and the von Frey test. l Quantitative analysis of hindpaw withdrawal time responding to temperature (hot plate test, ** P < 0.01, n = 8). m , n Quantitative analysis of hindpaw withdrawal frequency responding to mechanical stimulation (von Frey test, 0.7 mN and 3.9 mN, * P < 0.05, ** P < 0.01, n = 8). o Quantitative analysis of Basso Mouse Scale (BMS) score between Tgfb1 flox / flox control mice after SCI, Tgfb1 LysM-cre −/− mice after SCI, and Tgfb1 flox/flox control mice without SCI (* P < 0.05, n = 8). PWF paw withdrawal frequency. LF left forepaw, RF right forepaw, RH right hindpaw. Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file

    Article Snippet: We used antibodies recognizing mouse pSmad2 (1:1 000, Cell Signaling Technology, Inc., Danvers, MA, USA) and Smad2 (1:1 000, Cell Signaling Technology, Inc.) to examine the protein concentrations in the lysates.

    Techniques: Knock-Out, Functional Assay, Enzyme-linked Immunosorbent Assay, Concentration Assay, Western Blot, Activation Assay, Staining, Derivative Assay, Immunofluorescence, Hot Plate Test, Control

    Conditional knockout of TGF-β type 2 receptor ( Tgfbr2 ) in pericytes reduces fibrotic scar formation in SCI mice. a Schematic diagram of Tgfbr2 knockout in Glast-Cre + pericytes. b Representative images of immunofluorescent analysis of PGP9.5 + (red) nerve fibers, fibronectin + (green) fibrotic scar, and DAPI (blue) staining of nuclei at 4 weeks after SCI. Scale bar, 200 µm. c , d Quantitative analysis of the intensity value of PGP9.5 and fibronectin (* P < 0.05, n = 6). e Representative images of immunofluorescent analysis of nerve axon–specific β-III-tubulin + (green), collagen III + (red) fibrotic scar, and DAPI (blue) staining of nuclei at 4 weeks after SCI. Scale bar, 200 µm. Right images are high resolution versions of the boxed regions in the left images. Scale bar, 50 µm. f Quantitative analysis of the intensity value of collagen III (* P < 0.05, n = 6). g Representative images of immunofluorescent analysis of neurotransmitter marker 5-HT + (red), nerve axon–specific β-III-tubulin + (green), and DAPI (blue) staining of nuclei in spinal cord lesion site of T10 in Tgfbr2 flox/flox sham group mice, Tgfbr2 flox/flox control mice, and Tgfbr2 Glast-creER −/− mice at 4 weeks after SCI. Scale bar, 200 µm. Right images are high-resolution versions of the boxed regions in the left images. Scale bar, 50 µm. h , i Quantitative analysis of the intensity value of 5-HT and β-III-tubulin (* P < 0.05, n = 6). j Representative images of immunofluorescent analysis of pSmad2 + (red), PDGFR-β + (green) pericytes and DAPI (blue) staining of nuclei at 7 days after SCI. Scale bar, 10 µm. k , l Quantitative analysis of the intensity mean value of PDGFR-β and the number of pSmad2 + cells (*** P < 0.001, **** P < 0.000 1, n = 6). m Representative Western blots showing the activation of pSmad signaling. Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file

    Journal: Bone Research

    Article Title: TGF-β-induced fibrotic scar formation limits recovery of spinal cord injury

    doi: 10.1038/s41413-026-00507-7

    Figure Lengend Snippet: Conditional knockout of TGF-β type 2 receptor ( Tgfbr2 ) in pericytes reduces fibrotic scar formation in SCI mice. a Schematic diagram of Tgfbr2 knockout in Glast-Cre + pericytes. b Representative images of immunofluorescent analysis of PGP9.5 + (red) nerve fibers, fibronectin + (green) fibrotic scar, and DAPI (blue) staining of nuclei at 4 weeks after SCI. Scale bar, 200 µm. c , d Quantitative analysis of the intensity value of PGP9.5 and fibronectin (* P < 0.05, n = 6). e Representative images of immunofluorescent analysis of nerve axon–specific β-III-tubulin + (green), collagen III + (red) fibrotic scar, and DAPI (blue) staining of nuclei at 4 weeks after SCI. Scale bar, 200 µm. Right images are high resolution versions of the boxed regions in the left images. Scale bar, 50 µm. f Quantitative analysis of the intensity value of collagen III (* P < 0.05, n = 6). g Representative images of immunofluorescent analysis of neurotransmitter marker 5-HT + (red), nerve axon–specific β-III-tubulin + (green), and DAPI (blue) staining of nuclei in spinal cord lesion site of T10 in Tgfbr2 flox/flox sham group mice, Tgfbr2 flox/flox control mice, and Tgfbr2 Glast-creER −/− mice at 4 weeks after SCI. Scale bar, 200 µm. Right images are high-resolution versions of the boxed regions in the left images. Scale bar, 50 µm. h , i Quantitative analysis of the intensity value of 5-HT and β-III-tubulin (* P < 0.05, n = 6). j Representative images of immunofluorescent analysis of pSmad2 + (red), PDGFR-β + (green) pericytes and DAPI (blue) staining of nuclei at 7 days after SCI. Scale bar, 10 µm. k , l Quantitative analysis of the intensity mean value of PDGFR-β and the number of pSmad2 + cells (*** P < 0.001, **** P < 0.000 1, n = 6). m Representative Western blots showing the activation of pSmad signaling. Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file

    Article Snippet: We used antibodies recognizing mouse pSmad2 (1:1 000, Cell Signaling Technology, Inc., Danvers, MA, USA) and Smad2 (1:1 000, Cell Signaling Technology, Inc.) to examine the protein concentrations in the lysates.

    Techniques: Knock-Out, Staining, Marker, Control, Western Blot, Activation Assay

    Neonatal mice completely recover from SCI without scarring. a Schematic diagram illustrating the timeline of the experimental procedures. b Representative images of immunofluorescent analysis of pSmad2 (red), PDGFR-β (green), and DAPI (blue) in the spinal cord lesion site in neonatal mice on days 2, 7, and 12 with or without SCI. Scale bar, 50 µm. Right images are high-resolution versions of the boxed regions in the left images. Scale bar, 50 µm. c , d Quantitative analysis of the number of pSmad2 + cells and PDGFR-β + cells (** P < 0.01, *** P < 0.001, **** P < 0.000 1, n = 6). e Representative images of immunofluorescent analysis of β-III-tubulin (green), collagen III (red), and DAPI (blue) in the spinal cord lesion site in neonatal mice on days 2 and 12, and adult mice with or without SCI. Scale bar, 200 µm. f , g Quantitative analysis of the intensity mean value of collagen III + fibrotic scar and β-III-tubulin + nerves (* P < 0.05, **** P < 0.000 1, n = 6). Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file

    Journal: Bone Research

    Article Title: TGF-β-induced fibrotic scar formation limits recovery of spinal cord injury

    doi: 10.1038/s41413-026-00507-7

    Figure Lengend Snippet: Neonatal mice completely recover from SCI without scarring. a Schematic diagram illustrating the timeline of the experimental procedures. b Representative images of immunofluorescent analysis of pSmad2 (red), PDGFR-β (green), and DAPI (blue) in the spinal cord lesion site in neonatal mice on days 2, 7, and 12 with or without SCI. Scale bar, 50 µm. Right images are high-resolution versions of the boxed regions in the left images. Scale bar, 50 µm. c , d Quantitative analysis of the number of pSmad2 + cells and PDGFR-β + cells (** P < 0.01, *** P < 0.001, **** P < 0.000 1, n = 6). e Representative images of immunofluorescent analysis of β-III-tubulin (green), collagen III (red), and DAPI (blue) in the spinal cord lesion site in neonatal mice on days 2 and 12, and adult mice with or without SCI. Scale bar, 200 µm. f , g Quantitative analysis of the intensity mean value of collagen III + fibrotic scar and β-III-tubulin + nerves (* P < 0.05, **** P < 0.000 1, n = 6). Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file

    Article Snippet: We used antibodies recognizing mouse pSmad2 (1:1 000, Cell Signaling Technology, Inc., Danvers, MA, USA) and Smad2 (1:1 000, Cell Signaling Technology, Inc.) to examine the protein concentrations in the lysates.

    Techniques: